Literature DB >> 10713869

Comparison of anti-emetic effects of ondansetron, metoclopromide or a combination of both in children undergoing surgery for strabismus.

S Kathirvel1, D Shende, R Madan.   

Abstract

This prospective, randomized and double-blinded study was designed to evaluate the anti-emetic efficacy of a combination of ondansetron and metoclopramide in 100 ASA physical status I and II children of either sex and 1-15 years of age undergoing elective surgery for strabismus. A standardized anaesthetic technique and post-operative analgesia were used for all the children. Children were divided into four groups. They received saline, metoclopromide 250 micrograms kg-1, ondansetron 150 micrograms kg-1 or a combination of metoclopramide 150 micrograms kg-1 and ondansetron 100 micrograms kg-1 intravenously immediately after the insertion of an intravenous cannulae. There were no differences between the groups in their age, gender, weight, duration of surgery, number of muscles subjected to surgery or intravenous fluids received. In the first 24 post-operative hours, 18 (72%) patients in the placebo group, 15 (60%) patients in the metoclopramide group, 10 (40%) patients in the ondansetron group and 11 (44%) patients in the combination group had nausea or vomiting. The overall incidence of post-operative nausea and vomiting was significantly (P < 0.05) lower in the combination group and in the ondansetron group compared with the placebo group. Nine (36%) patients in both the placebo and the metoclopramide groups and one (4%) patient in the ondansetron group required rescue anti-emetic treatment. None of the patients in the combination group required rescue anti-emetic and this was significantly less (P < 0.01) when compared with the placebo and the metoclopramide groups. Recovery and sedation scores were comparable in all the four groups. A combination of metoclopramide 150 micrograms kg-1 and ondansetron 100 micrograms kg-1 administered prior to surgery was not found to be more effective than ondansetron 150 micrograms kg-1 alone for the prophylaxis of nausea and vomiting following surgical repair of strabismus in paediatric patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10713869     DOI: 10.1046/j.1365-2346.1999.00580.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

Review 1.  Ondansetron: a review of its use as an antiemetic in children.

Authors:  C R Culy; N Bhana; G L Plosker
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Update on the management of postoperative nausea and vomiting.

Authors:  Anthony L Kovac
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 3.  RETRACTED ARTICLE: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting : Focus on High-Risk Patients.

Authors:  Yoshitaka Fujii
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

Review 4.  Management of postoperative nausea and vomiting in children.

Authors:  Anthony L Kovac
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  Management of postoperative nausea and vomiting in children.

Authors:  Pasquale De Negri; Giorgio Ivani
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis.

Authors:  Melissa Lau Moon Lin; Paula D Robinson; Jacqueline Flank; Lillian Sung; L Lee Dupuis
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

7.  Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgery.

Authors:  Deborah S Wagner; Virginia Gauger; Devi Chiravuri; Kristin Faust
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.